Michelle Min, MD, MS, reviewed best practices for managing cutaneous lupus and discussed emerging therapies practitioners ...

Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...

Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...

Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them are FDA-approved.

An active acupressure intervention offers clinical benefits for patients with rosacea when combined with pharmacotherapy.

Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...

BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents ...

Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.

Investigators studied treatment patterns among patients with generalized pustular psoriasis (GPP) to determine the use of GPP-specific therapies. Corticosteroids remained the primary therapy overall, ...

Phase 3b TOGETHER trial results presented at FC26 show concomitant ixekizumab and tirzepatide significantly improve joint and skin outcomes while driving meaningful weight loss in patients with ...